William Blair Reiterates Outperform Rating on Veeva Systems (VEEV) amid Ostro acquisition

Tue, 10 Mar 2026 14:34:14 -0400

William Blair analyst Dylan Becker reiterated an Outperform rating on Veeva Systems (NYSE: VEEV)

The analyst commented, "We believe this acquisition is highly aligned with Veeva’s strategy of embedding best-in-class AI intelligence across core commercial and developmental workflows. More specifically, on the commercial side, Veeva has prioritized building the future of medical, legal, and regulatory (MLR) review, an extension of the company’s leading PromoMats offering, through AI functionality to enable a faster path to approved content. Ostro’s capabilities are highly complementary to this goal, as Ostro’s generated answers are drawn directly from MLR-approved materials making them 100% compliant. Further, as integrations

Veeva acquires Ostro for $100 million to expand AI customer engagement

Tue, 10 Mar 2026 11:45:16 -0400

Veeva Systems (NYSE: VEEV) announced the acquisition of Ostro for approximately $100 million in cash and long-term equity retention grants. The deal adds an AI-driven brand engagement platform designed for life sciences companies.

Ostro operates brand websites that allow patients and healthcare providers to ask questions and receive real-time responses using conversational AI and semantic search technology. The platform draws responses from MLR-approved materials and includes compliance guardrails specific to the life sciences industry.

"AI has changed how people get information. It's no longer about how much information you can put out there, it's about how easy it is for customers to

Veeva acquires Ostro for $100 million to expand AI customer engagement

Tue, 10 Mar 2026 11:45:16 -0400

"AI has changed how people get information. It's no longer about how much information you can put out there, it's about how easy it is for customers to

Veeva Acquires Ostro, the Leading Brand Engagement Platform for Life Sciences

Tue, 10 Mar 2026 11:45:00 -0400

PLEASANTON, Calif., March 10, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced the acquisition of Ostro, the leading brand engagement platform for life sciences that gives patients and doctors immediate, compliant answers through an easy-to-use AI-driven chat experience.

Veeva Acquires Ostro, the Leading Brand Engagement Platform for Life Sciences

Tue, 10 Mar 2026 11:45:00 -0400

Veeva Acquires Ostro, the Leading Brand Engagement Platform for Life Sciences

Tue, 10 Mar 2026 11:45:00 -0400

Veeva Acquires Ostro, the Leading Brand Engagement Platform for Life Sciences

Tue, 10 Mar 2026 11:45:00 -0400

AOP Health Standardizes on Veeva Industry Cloud for Life Sciences Across All Business Areas

Tue, 10 Mar 2026 09:01:00 -0400

International biopharma specializing in rare diseases and critical care connects R&D, quality, commercial, and data on the Veeva Vault Platform to accelerate innovation

PLEASANTON, Calif. and VIENNA, March 10, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that AOP Health, an international leader in integrated therapies for rare diseases and critical care, is standardizing on applications across the Veeva Vault Platform to drive faster global growth. By connecting clinical research, development, quality, and commercialization on Veeva

AOP Health Standardizes on Veeva Industry Cloud for Life Sciences Across All Business Areas

Tue, 10 Mar 2026 09:01:00 -0400

International biopharma specializing in rare diseases and critical care connects R&D, quality, commercial, and data on the Veeva Vault Platform to accelerate innovation

AOP Health Standardizes on Veeva Industry Cloud for Life Sciences Across All Business Areas

Tue, 10 Mar 2026 09:01:00 -0400

International biopharma specializing in rare diseases and critical care connects R&D, quality, commercial, and data on the Veeva Vault Platform to accelerate innovation

AOP Health Standardizes on Veeva Industry Cloud for Life Sciences Across All Business Areas

Tue, 10 Mar 2026 09:01:00 -0400

International biopharma specializing in rare diseases and critical care connects R&D, quality, commercial, and data on the Veeva Vault Platform to accelerate innovation

Form 4 VEEVA SYSTEMS INC For: Mar 05 Filed by: Schwenger Thomas D.

Mon, 09 Mar 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20260309/26132768.html

Form 4 VEEVA SYSTEMS INC For: Mar 05 Filed by: Schwenger Thomas D.

Mon, 09 Mar 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20260309/26132768.html

Veeva Systems (VEEV) PT Raised to $220 at UBS

Thu, 05 Mar 2026 08:55:48 -0400

UBS analyst Karl Keirstead raised the price target on Veeva Systems (NYSE: VEEV) to $220.00 (from $200.00) while maintaining a Neutral rating.

Veeva Systems (VEEV) PT Raised to $215 at Morgan Stanley

Thu, 05 Mar 2026 08:09:32 -0400

Morgan Stanley analyst Craig Hettenbach raised the price target on Veeva Systems (NYSE: VEEV) to $215.00 (from $205.00) while maintaining a Equalweight rating.

Veeva Systems (VEEV) PT Lowered to $317 at Wells Fargo

Thu, 05 Mar 2026 07:27:06 -0400

Wells Fargo analyst Stan Berenshteyn lowered the price target on Veeva Systems (NYSE: VEEV) to $317.00 (from $333.00) while maintaining a Overweight rating.

Veeva Systems (VEEV) PT Lowered to $270 at Needham

Thu, 05 Mar 2026 07:12:06 -0400

(Updated - March 5, 2026 7:12 AM EST)

Needham analyst Ryan MacDonald lowered the price target on Veeva Systems (NYSE: VEEV) to $270.00 (from $355.00) while maintaining a Buy rating.

The analyst commented: "We reiterate our Buy rating on VEEV following a strong close to FY26, as continued progress penetrating top 20 pharma for Vault CRM has been supplemented by even higher win rates in the mid-market, resulting in 125+ customers now on Vault CRM. The early transition success, and rising product development in the AI space, is positioning Veeva as a centralized system regardless of AI adoption decisions made by life

Veeva Systems (VEEV) PT Lowered to $270 at Needham

Thu, 05 Mar 2026 07:12:06 -0400

(Updated - March 5, 2026 7:12 AM EST)

Needham analyst Ryan MacDonald lowered the price target on Veeva Systems (NYSE: VEEV) to $270.00 (from $355.00) while maintaining a Buy rating.

Veeva Systems (VEEV) PT Lowered to $235 at Canaccord

Thu, 05 Mar 2026 06:44:35 -0400

Canaccord analyst David Hynes Jr. lowered the price target on Veeva Systems (NYSE: VEEV) to $235.00 (from $280.00) while maintaining a Hold rating.

Veeva Systems (VEEV) PT Lowered to $275 at Raymond James

Thu, 05 Mar 2026 06:29:46 -0400

Raymond James analyst Brian Peterson lowered the price target on Veeva Systems (NYSE: VEEV) to $275.00 (from $320.00) while maintaining a Outperform rating.

The analyst comments "We’re maintaining our Outperform on shares of VEEV following F4Q results that broadly topped our expectations, with a low double-digit growth outlook that we believe should prove conservative. While Veeva isn’t immune from volatility in software sentiment, we believe shares look increasingly attractive given 1) a consistent GTM motion and growth profile in the low double digits that has shown little degradation in recent years; 2) strategic positioning with customers of vertical-specific software; 3) a

Veeva Systems (VEEV) PT Raised to $245 at Stifel

Thu, 05 Mar 2026 06:25:26 -0400

Stifel analyst David Grossman raised the price target on Veeva Systems (NYSE: VEEV) to $245.00 (from $212.00) while maintaining a Buy rating.

The analyst comments "Misc. Commentary • There has been noise in the marketplace from a competitor in the EDC segment (electronic data capture/Medidata) claiming/implying multiple competitive takeaways. Management reiterated they have lost only one client (Abbvie, known) and that any other competitive wins would be from other vendors. • The market narrative was likely fueled by a lull in top 20 EDC wins for VEEV, which can be very lumpy (individual products and related wins not consistently disclosed) •

Veeva Systems (VEEV) PT Raised to $245 at Stifel

Thu, 05 Mar 2026 06:25:26 -0400

Stifel analyst David Grossman raised the price target on Veeva Systems (NYSE: VEEV) to $245.00 (from $212.00) while maintaining a Buy rating.

Veeva Systems (VEEV) PT Lowered to $262 at Truist Securities

Thu, 05 Mar 2026 06:22:58 -0400

Truist Securities analyst Jailendra Singh lowered the price target on Veeva Systems (NYSE: VEEV) to $262.00 (from $275.00) while maintaining a Buy rating.

The analyst comments "Veeva delivered a solid FY4Q26, including billings, and issued FY27 guidance that was ahead of consensus across the board. Given cautious peer readthroughs, investors were expecting an in-line quarter and steady outlook. While macro visibility has improved in some areas, guidance assumes no major macro shifts and instead reflects customer planning cycles. Management reaffirmed a ~70% win rate within top-20 pharma, with decisions wrapping up this year. Reiterate Buy; adjust PT to $262 from $27."

Veeva Systems (VEEV) PT Lowered to $262 at Truist Securities

Thu, 05 Mar 2026 06:22:58 -0400

Truist Securities analyst Jailendra Singh lowered the price target on Veeva Systems (NYSE: VEEV) to $262.00 (from $275.00) while maintaining a Buy rating.

Veeva Systems (VEEV) PT Lowered to $275 at RBC Capital

Thu, 05 Mar 2026 04:59:31 -0400

RBC Capital analyst Rishi Jaluria lowered the price target on Veeva Systems (NYSE: VEEV) to $275.00 (from $330.00) while maintaining a Outperform rating.

The analyst comments "We view RYAM's messaging with its results as reflecting a significant acceleration in the value-over-volume and repricing strategy that had begun to play out over the past few years, and believe the positive market response (RYAM +16.5% vs. S&P500 +0.8%) was directionally appropriate given what seems to be a significant opportunity to grow CS (and to some degree, other segments') contribution over the medium term. We also continue to view AIP's recent interest at $11-12/share

StreetInsider.com News Articles

William Blair Reiterates Outperform Rating on Veeva Systems (VEEV) amid Ostro acquisition

Veeva acquires Ostro for $100 million to expand AI customer engagement

Veeva acquires Ostro for $100 million to expand AI customer engagement

Veeva Acquires Ostro, the Leading Brand Engagement Platform for Life Sciences

Veeva Acquires Ostro, the Leading Brand Engagement Platform for Life Sciences

Veeva Acquires Ostro, the Leading Brand Engagement Platform for Life Sciences

Veeva Acquires Ostro, the Leading Brand Engagement Platform for Life Sciences

AOP Health Standardizes on Veeva Industry Cloud for Life Sciences Across All Business Areas

AOP Health Standardizes on Veeva Industry Cloud for Life Sciences Across All Business Areas

AOP Health Standardizes on Veeva Industry Cloud for Life Sciences Across All Business Areas

AOP Health Standardizes on Veeva Industry Cloud for Life Sciences Across All Business Areas

Form 4 VEEVA SYSTEMS INC For: Mar 05 Filed by: Schwenger Thomas D.

Form 4 VEEVA SYSTEMS INC For: Mar 05 Filed by: Schwenger Thomas D.

Veeva Systems (VEEV) PT Raised to $220 at UBS

Veeva Systems (VEEV) PT Raised to $215 at Morgan Stanley

Veeva Systems (VEEV) PT Lowered to $317 at Wells Fargo

Veeva Systems (VEEV) PT Lowered to $270 at Needham

Veeva Systems (VEEV) PT Lowered to $270 at Needham

Veeva Systems (VEEV) PT Lowered to $235 at Canaccord

Veeva Systems (VEEV) PT Lowered to $275 at Raymond James

Veeva Systems (VEEV) PT Raised to $245 at Stifel

Veeva Systems (VEEV) PT Raised to $245 at Stifel

Veeva Systems (VEEV) PT Lowered to $262 at Truist Securities

Veeva Systems (VEEV) PT Lowered to $262 at Truist Securities

Veeva Systems (VEEV) PT Lowered to $275 at RBC Capital